hematologic malignancy

hematologic malignancy

Hematologic cancer Hematology Any CA of blood-forming tissues, BM, or lymph nodes–eg, leukemia and lymphoma
References in periodicals archive ?
AML is a hematologic malignancy characterized by the accumulation of clonal myeloid progenitor cells in the blood or bone marrow.
The substantial burden imposed by dermatologic complications in patients with cancer, particularly a hematologic malignancy, highlights the importance of greater collaboration between oncology and dermatology services to mitigate the impact of these events on both quality of life and outcome, wrote Gregory S.
Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer.
Risk factors include diabetes mellitus, hematologic malignancy, receiving hematopoietic stem cell transplant, deferoxamine therapy, injection drug use, and trauma or burns [1-4].
Acute myeloid leukemia is a hematologic malignancy in which myeloid lineage cells of the bone marrow cease to differentiate appropriately, resulting in a marked increase in the number of circulating immature blast cells.
b) Hematologic malignancy that develops due to abnormal growth of lymphocytes
Todays CHMP positive opinion marks an important milestone in applying our Immuno-Oncology science to delivering a treatment option for patients with this hematologic malignancy. If approved by the European Commission, Opdivo will become the first PD-1 inhibitor approved to treat a hematologic malignancy in the European Union, further building on our established heritage in blood cancer care.
Forty-five patients with a diagnosis of hematologic malignancy were identified in a database of more than 3600 consecutive cases of malignant mesothelioma, which comprised mainly professional and medicolegal consultation cases from 1982 to 2013.
HEV was diagnosed concomitantly to the onset (n = 2) or at relapse (n = 2) of the hematologic malignancy, which raises the hypothesis of an association between HEV infection and carcinogenesis (13).
CMML is a life-threatening hematologic malignancy characterized by elevated levels of monocytes, immature blood cells, or blast cells, and abnormal cells in the peripheral blood as well as in the bone marrow.
(5-15) Hodgkin's lymphoma as first hematologic malignancy reported neoplasm in sickle cell disease in 1938.
They address neonatal hematology, bone marrow failure, disorders of erythrocyte production, hemolytic anemias, disorders of hemoglobin, the phagocyte system and disorders, the immune system and diseases, storage diseases, hemostasis, supportive therapy, hematologic manifestations of systemic diseases, the biology of cancer, cancer therapeutics, hematologic malignancy, solid tumors, and supportive care.